Skip to main content

Signed · Poland · Pharma and biotech

Verfora agrees to acquire a majority stake in Qpharma.

Verfora, the consumer healthcare company of the Swiss Galenica group, based in Villars-sur-Glâne, announced on 18 November 2026 that it is taking over 51% of the shares in Qpharma, a family-run Polish pharmaceutical distributor that already sells Verfora products and holds exclusive distribution rights for several brands in Poland, the Czech Republic and Slovakia. Qpharma had 2025 sales in the low double-digit millions of euros. Completion is subject to regulatory approvals. It was signed on 18 November 2026. It had not completed by 18 November 2026.

SigningDay 100

Signing 18 November 2026

Buyer
Verfora AG ·Villars-sur-Glâne, Switzerland
Target
Qpharma Sp. z o.o. ·Warsaw, Poland
Type
Majority stake
Announced
18 November 2026
Signed
18 November 2026
Value
Not disclosed
People
Not stated in the release
Last checked
18 November 2026

The people side in Poland

Octagon runs payroll in Poland for international buyers, with or without a local entity of their own.

Related deals

Get the briefing

Deals into Europe lists public facts with their sources, checked every working day by Octagon Professionals International. Corrections go to info@octagon.nl and are made within one working day. How we track deals.

Enabling organisations to operate across borders with clarity, compliance, and trust.

All deals into Europe